Company intelligence / Profile preview

Actis

Visakhapatnam, Andhra Pradesh, Indiaact.is ↗

Ownership: Private
Development stage: Other

Overview

Actis Generics manufactures bulk drugs, active pharmaceutical ingredients (APIs), key starting materials (KSMs), and specialty chemicals used in human medicines. The company supplies primarily to domestic Indian pharmaceutical companies with some exports to Europe. It does not have its own clinical pipeline but supports drug manufacturing for others.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

BioconMSN LaboratoriesLupin LimitedIntas Pharmaceuticals

Beyond the preview

Go deeper on Actis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actis.

Explore the full profile